2013
Increased Cigarette Tax is Associated with Reductions in Alcohol Consumption in a Longitudinal U.S. Sample
Young‐Wolff K, Kasza KA, Hyland AJ, McKee SA. Increased Cigarette Tax is Associated with Reductions in Alcohol Consumption in a Longitudinal U.S. Sample. Alcohol Clinical And Experimental Research 2013, 38: 241-248. PMID: 23930623, PMCID: PMC3830619, DOI: 10.1111/acer.12226.Peer-Reviewed Original ResearchConceptsAlcohol consumptionPublic health benefitsInverse associationCigarette taxesLongitudinal U.S. sampleHealth benefitsYoung adult smokersSmoking-related outcomesFrequency of bingeBaseline alcohol consumptionNational Epidemiological SurveyBinge drinking frequencyMale smokersAdult smokersAlcohol consumersStratified analysisCigarette taxationDrinking statusEpidemiological studiesMultiple linear regression analysisHazardous drinkersSmokersEpidemiological surveyHealth behaviorsLinear regression analysis
2012
Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking
Toll BA, Cummings KM, O'Malley SS, Carlin‐Menter S, McKee SA, Hyland A, Wu R, Hopkins J, Celestino P. Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking. Alcohol Clinical And Experimental Research 2012, 36: 1653-1658. PMID: 22703028, PMCID: PMC3436938, DOI: 10.1111/j.1530-0277.2012.01767.x.Peer-Reviewed Original ResearchConceptsSmoking cessation ratesCessation ratesBrief alcohol interventionHazardous drinkingHigh-risk drinkersQuitline callersTobacco quitlineCessation outcomesNIAAA guidelinesAlcohol interventionsLower smoking cessation ratesModerate alcohol consumptionShort-term followQuarter of smokersHazardous drinking patternsHigh rateSmoking cessationDaily smokersModerate drinkersSmoking relapseHazardous drinkersAlcohol consumptionSmokersDrinking patternsQuitlineSmoke-free bar policies and smokers’ alcohol consumption: Findings from the International Tobacco Control Four Country Survey
Kasza KA, McKee SA, Rivard C, Hyland AJ. Smoke-free bar policies and smokers’ alcohol consumption: Findings from the International Tobacco Control Four Country Survey. Drug And Alcohol Dependence 2012, 126: 240-245. PMID: 22704125, PMCID: PMC3660989, DOI: 10.1016/j.drugalcdep.2012.05.022.Peer-Reviewed Original ResearchConceptsSmoke-free policiesAlcohol consumptionInternational Tobacco Control Four Country SurveyFour Country SurveyBar policiesIndoor smoke-free policiesSecond-hand smokeHeavy smokersCigarette smokingAmount of alcoholHazardous drinkersSmoking bansPotential associationSmall reductionConcurrent useCountry SurveySmokersSmokingDrinking behaviorHealth risksRepresentative sampleHarmful effectsSingular useDrinkers
2008
Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder
Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS. Risk factors for treatment failure in smokers: Relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine & Tobacco Research 2008, 10: 1793-1809. PMID: 19023831, PMCID: PMC2764010, DOI: 10.1080/14622200802443742.Peer-Reviewed Original ResearchConceptsHeavy drinking daysAlcohol use disorderAUD historyCessation relapseUse disordersDrinking daysModerate drinkingAlcohol useSustained-release bupropionLifetime alcohol use disorderModerate alcohol usersRandomized clinical trialsAlcohol use categoriesProbability of smokingSmoking cessation failureTreatment failureAlcohol use levelsRisk factorsClinical trialsHazardous patternsTreatment periodHazardous drinkersAbstinent daysCessation failureAlcohol usersDose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation
O'Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, Makuch RW. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. The International Journal Of Neuropsychopharmacology 2008, 12: 589-597. PMID: 18796184, PMCID: PMC3094855, DOI: 10.1017/s146114570800936x.Peer-Reviewed Original ResearchConceptsHazardous drinkingSmoking cessationFavorable side effect profileDose-ranging clinical trialAlcohol useEffects of NTXPlacebo-controlled trialDose-ranging trialSide effect profileTransdermal nicotine patchOpiate antagonist naltrexoneDose-dependent reductionComponent of treatmentHazardous alcohol useOral NTXSecondary outcomesNicotine patchPrimary outcomeAntagonist naltrexoneCombination therapyClinical trialsBaseline predictorsOral preparationsHazardous drinkersNTX